Cargando…
Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
We studied five pathological specimens from five patients at 1.5, 3.0, 4.0, 13.5, and 14.0 months after radiotherapy for HCC. Four needle biopsies were obtained to investigate liver parenchyma of focal liver reaction (FLR) around treated HCC, when patients had newly developed HCC or local recurrence...
Autores principales: | Okada, Masahiro, Numata, Kazushi, Nihonmatsu, Hiromi, Tomita, Kengo, Takeda, Atsuya, Tago, Kenichiro, Hyodo, Tomoko, Eriguchi, Takahisa, Nakano, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139971/ https://www.ncbi.nlm.nih.gov/pubmed/35626228 http://dx.doi.org/10.3390/diagnostics12051072 |
Ejemplares similares
-
Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021) -
Three Cases of Hepatocellular Carcinoma With Massive Macrovascular Invasion Successfully Treated With Radiotherapy
por: Tsurugai, Yuichiro, et al.
Publicado: (2021) -
Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021) -
Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021) -
Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer
por: Sanuki, Naoko, et al.
Publicado: (2022)